Cochrane · systematic review · CD010699
Belatacept for kidney transplant recipients
Masson, P, Henderson, L, Chapman, JR, et al. · Cochrane Database of Systematic Reviews · 2014 · Cochrane Library
Kidney and TransplantAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
9
current version
GRADE rated
9
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 4 · 44.4%High 5 · 55.6%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Comparison
Population: Kidney transplant recipients
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Death | no estimate extracted | 4 studies · 1516 participants | High |
Loss of kidney transplant | no estimate extracted | 4 studies · 1516 participants | High |
Acute rejection | no estimate extracted | 4 studies · 1516 participants | High |
Chronic kidney scarring | no estimate extracted | 3 studies · 1350 participants | High |
Malignancy | no estimate extracted | 4 studies · 1516 participants | Moderate |
PTLD | no estimate extracted | 4 studies · 1516 participants | Moderate |
New onset diabetes | no estimate extracted | 4 studies · 1049 participants | Moderate |
Delayed graft function | no estimate extracted | 2 studies · 1209 participants | High |
Presence of donor specific antibodies | no estimate extracted | 2 studies · 1209 participants | Moderate |